multiple-sclerosis

Documents about multiple-sclerosis

• Propionic Acid in Multiple Sclerosis#851725ClinicalTrials.gov
• Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate#860573ClinicalTrials.gov
• Acute Intermittent Hypoxia in Persons With Multiple Sclerosis#864882ClinicalTrials.gov
• Balance and Falls in Multiple Sclerosis#869151ClinicalTrials.gov
• Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study#880560ClinicalTrials.gov
• MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect#882151ClinicalTrials.gov
• Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II#882299ClinicalTrials.gov
• Multiple Sclerosis Registry in Argentina (RelevarEM)#884658ClinicalTrials.gov
• Exercise Therapy in Multiple Sclerosis#893083ClinicalTrials.gov
• Exergaming in Persons With Multiple Sclerosis With Restless Legs Syndrome#917804ClinicalTrials.gov
• Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)#847438ClinicalTrials.gov
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis#905007ClinicalTrials.gov
• Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)#864055ClinicalTrials.gov
• Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis#300310ClinicalTrials.gov
• Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis#802784ClinicalTrials.gov
• Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial#804015ClinicalTrials.gov
• Physical Activity and Fatigue in Early Multiple Sclerosis (MS)#806037ClinicalTrials.gov
• Natalizumab High Titer Immunogenicity and Safety#806807ClinicalTrials.gov
• Validation of a Shared Decision-Making Tool for Multiple Sclerosis#836138ClinicalTrials.gov
• Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis#851650ClinicalTrials.gov
• Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis#853018ClinicalTrials.gov
• Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis#853264ClinicalTrials.gov
• DreaMS - Digital Biomarkers for Multiple Sclerosis#855958ClinicalTrials.gov
• Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis#859754ClinicalTrials.gov
• A Pilot Study to Explore the Role of Gut Flora in Multiple Sclerosis#867949ClinicalTrials.gov
• Motor-cognitive Performance in People With Multiple Sclerosis#879563ClinicalTrials.gov
• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis#882378ClinicalTrials.gov
• A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis#888699ClinicalTrials.gov
• Melatonin in Relapsing-Remitting Multiple Sclerosis Patients#894924ClinicalTrials.gov
• Cannabis for Spasticity in Multiple Sclerosis#898260ClinicalTrials.gov
• Yoga in Multiple Sclerosis Patients#906955ClinicalTrials.gov
• Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients#918963ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis#801302ClinicalTrials.gov
• Motor Evoked Potentials With Modified Facilitation Technique#861821ClinicalTrials.gov
• Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)#838383ClinicalTrials.gov
• Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran#825077ClinicalTrials.gov
• Improving Hand Use in Multiple Sclerosis#875622ClinicalTrials.gov
• Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis#916982ClinicalTrials.gov
• Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients#307413ClinicalTrials.gov
• Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis#628622ClinicalTrials.gov
• BX-1 in Spasticity Due to Multiple Sclerosis#802773ClinicalTrials.gov
• Measuring Blood Vessel Density in the Optic Nerve of Multiple Sclerosis Patients With OCTA#811049ClinicalTrials.gov
• Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients#812482ClinicalTrials.gov
• Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis#827215ClinicalTrials.gov
• Task-oriented Circuit Class Training in Multiple Sclerosis Subjects#829009ClinicalTrials.gov
• Use of Cannabinoids in Patients With Multiple Sclerosis#836438ClinicalTrials.gov
• Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis#842555ClinicalTrials.gov
• Cognitive Evolution in Tysabri Treated Multiple Sclerosis Patients - A Three Year Extension#847755ClinicalTrials.gov
• A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition#858940ClinicalTrials.gov
• Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients#860417ClinicalTrials.gov